Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Deimination restores inner retinal visual function in murine demyelinating disease.

Enriquez-Algeciras M, Ding D, Mastronardi FG, Marc RE, Porciatti V, Bhattacharya SK.

J Clin Invest. 2013 Feb;123(2):646-56. doi: 10.1172/JCI64811. Epub 2013 Jan 2.

2.

Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosis.

Moscarello MA, Lei H, Mastronardi FG, Winer S, Tsui H, Li Z, Ackerley C, Zhang L, Raijmakers R, Wood DD.

Dis Model Mech. 2013 Mar;6(2):467-78. doi: 10.1242/dmm.010520. Epub 2012 Nov 1.

3.

Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system.

Musse AA, Li Z, Ackerley CA, Bienzle D, Lei H, Poma R, Harauz G, Moscarello MA, Mastronardi FG.

Dis Model Mech. 2008 Nov-Dec;1(4-5):229-40. doi: 10.1242/dmm.000729. Epub 2008 Nov 6.

4.

Myelin localization of peptidylarginine deiminases 2 and 4: comparison of PAD2 and PAD4 activities.

Wood DD, Ackerley CA, Brand Bv, Zhang L, Raijmakers R, Mastronardi FG, Moscarello MA.

Lab Invest. 2008 Apr;88(4):354-64. doi: 10.1038/labinvest.3700748. Epub 2008 Jan 28.

5.

Synergy between paclitaxel plus an exogenous methyl donor in the suppression of murine demyelinating diseases.

Mastronardi FG, Tsui H, Winer S, Wood DD, Selvanantham T, Galligan C, Fish EN, Dosch HM, Moscarello MA.

Mult Scler. 2007 Jun;13(5):596-609. Epub 2007 Feb 9.

PMID:
17548438
6.

Peptidyl argininedeiminase 2 CpG island in multiple sclerosis white matter is hypomethylated.

Mastronardi FG, Noor A, Wood DD, Paton T, Moscarello MA.

J Neurosci Res. 2007 Jul;85(9):2006-16.

PMID:
17469138
7.

Increased citrullination of histone H3 in multiple sclerosis brain and animal models of demyelination: a role for tumor necrosis factor-induced peptidylarginine deiminase 4 translocation.

Mastronardi FG, Wood DD, Mei J, Raijmakers R, Tseveleki V, Dosch HM, Probert L, Casaccia-Bonnefil P, Moscarello MA.

J Neurosci. 2006 Nov 1;26(44):11387-96.

8.

The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis.

Moscarello MA, Mastronardi FG, Wood DD.

Neurochem Res. 2007 Feb;32(2):251-6. Epub 2006 Sep 22. Review.

9.

Molecules affecting myelin stability: a novel hypothesis regarding the pathogenesis of multiple sclerosis.

Mastronardi FG, Moscarello MA.

J Neurosci Res. 2005 May 1;80(3):301-8. Review.

PMID:
15704220
10.

Expression of stathmin, a developmentally controlled cytoskeleton-regulating molecule, in demyelinating disorders.

Liu A, Stadelmann C, Moscarello M, Bruck W, Sobel A, Mastronardi FG, Casaccia-Bonnefil P.

J Neurosci. 2005 Jan 19;25(3):737-47.

11.
12.

The amount of sonic hedgehog in multiple sclerosis white matter is decreased and cleavage to the signaling peptide is deficient.

Mastronardi FG, daCruz LA, Wang H, Boggs J, Moscarello MA.

Mult Scler. 2003 Aug;9(4):362-71.

PMID:
12926841
13.

Multiple sclerosis: an important role for post-translational modifications of myelin basic protein in pathogenesis.

Kim JK, Mastronardi FG, Wood DD, Lubman DM, Zand R, Moscarello MA.

Mol Cell Proteomics. 2003 Jul;2(7):453-62. Epub 2003 Jun 25.

14.

Peptidylarginine deiminase: a candidate factor in demyelinating disease.

Moscarello MA, Pritzker L, Mastronardi FG, Wood DD.

J Neurochem. 2002 Apr;81(2):335-43.

15.

Co-localization of patched and activated sonic hedgehog to lysosomes in neurons.

Mastronardi FG, Dimitroulakos J, Kamel-Reid S, Manoukian AS.

Neuroreport. 2000 Feb 28;11(3):581-5.

PMID:
10718318
16.

Genetic analysis of protein kinase B (AKT) in Drosophila.

Staveley BE, Ruel L, Jin J, Stambolic V, Mastronardi FG, Heitzler P, Woodgett JR, Manoukian AS.

Curr Biol. 1998 May 7;8(10):599-602.

17.

Myelin basic protein in experimental allergic encephalomyelitis is not affected at the posttranslational level: implications for demyelinating disease.

Mastronardi FG, al-Sabbagh A, Nelson PA, Rego J, Roots BI, Moscarello MA.

J Neurosci Res. 1996 May 15;44(4):344-9.

PMID:
8739153
18.

Loss of myelin basic protein cationicity in DM20 transgenic mice is dosage dependent.

Mastronardi FG, Ackerley CA, Roots BI, Moscarello MA.

J Neurosci Res. 1996 May 15;44(4):301-7.

PMID:
8739149
19.

Identification of a mitogen-activated protein kinase site in human myelin basic protein in situ.

Yon M, Ackerley CA, Mastronardi FG, Groome N, Moscarello MA.

J Neuroimmunol. 1996 Mar;65(1):55-9.

PMID:
8642064
20.

Modifications of myelin basic protein in DM20 transgenic mice are similar to those in myelin basic protein from multiple sclerosis.

Mastronardi FG, Mak B, Ackerley CA, Roots BI, Moscarello MA.

J Clin Invest. 1996 Jan 15;97(2):349-58.

21.

ADP-ribosyltransferase activity in myelin membranes isolated from human brain.

Boulias C, Mastronardi FG, Moscarello MA.

Neurochem Res. 1995 Nov;20(11):1269-77.

PMID:
8786812
22.

Isolation and identification of proteolipid proteins in jimpy mouse brain.

Fannon AM, Mastronardi FG, Moscarello MA.

Neurochem Res. 1994 Aug;19(8):1005-12.

PMID:
7528345
23.

Demyelination in a transgenic mouse: a model for multiple sclerosis.

Mastronardi FG, Ackerley CA, Arsenault L, Roots BI, Moscarello MA.

J Neurosci Res. 1993 Oct 15;36(3):315-24.

PMID:
7505836
24.

Characterization of basic proteins from goldfish myelin.

Mastronardi FG, Boulias C, Roots BI, Moscarello MA.

J Neurochem. 1993 Jan;60(1):153-60.

PMID:
7678038

Supplemental Content

Loading ...
Support Center